ArticleNature communications2024

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.

Tomás A Martins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.